Literature DB >> 21869838

WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission.

Y Hashii, E Sato-Miyashita, R Matsumura, S Kusuki, H Yoshida, H Ohta, N Hosen, A Tsuboi, Y Oji, Y Oka, H Sugiyama, K Ozono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21869838     DOI： 10.1038/leu.2011.226

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  21 in total

1.  Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.

Authors:  Nirali N Shah; David M Loeb; Hahn Khuu; David Stroncek; Tolu Ariyo; Mark Raffeld; Cindy Delbrook; Crystal L Mackall; Alan S Wayne; Terry J Fry
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 2.  Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients.

Authors:  Naoki Hosen; Tetsuo Maeda; Yoshiko Hashii; Akihiro Tsuboi; Sumiyuki Nishida; Jun Nakata; Yusuke Oji; Yoshihiro Oka; Haruo Sugiyama
Journal:  Stem Cell Investig       Date:  2016-12-09

Review 3.  Immunotherapy in pediatric malignancies: current status and future perspectives.

Authors:  Christian M Capitini; Mario Otto; Kenneth B DeSantes; Paul M Sondel
Journal:  Future Oncol       Date:  2014       Impact factor: 3.404

4.  Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.

Authors:  J-H Yoon; H-J Kim; J-W Kim; Y-W Jeon; S-H Shin; S-E Lee; B-S Cho; K-S Eom; Y-J Kim; S Lee; C-K Min; S-G Cho; J-W Lee; W-S Min; C-W Park
Journal:  Bone Marrow Transplant       Date:  2014-08-11       Impact factor: 5.483

5.  Identification of mouse helper epitopes for WT1-specific CD4+ T cells.

Authors:  Hiroko Nakajima; Jun Nakata; Kanako Imafuku; Hiromu Hayashibara; Kazuki Isokawa; Keiko Udaka; Fumihiro Fujiki; Soyoko Morimoto; Kana Hasegawa; Naoki Hosen; Yoshiko Hashii; Sumiyuki Nishida; Akihiro Tsuboi; Yoshihiro Oka; Yusuke Oji; Shinji Sogo; Haruo Sugiyama
Journal:  Cancer Immunol Immunother       Date:  2021-07-16       Impact factor: 6.968

Review 6.  Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Authors:  Nan Li; Madeline R Spetz; Dan Li; Mitchell Ho
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

Review 7.  Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.

Authors:  Antonio Di Stasi; Antonio M Jimenez; Kentaro Minagawa; Mustafa Al-Obaidi; Katayoun Rezvani
Journal:  Front Immunol       Date:  2015-02-04       Impact factor: 7.561

8.  Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.

Authors:  Sumiyuki Nishida; Shigeo Koido; Yutaka Takeda; Sadamu Homma; Hideo Komita; Akitaka Takahara; Satoshi Morita; Toshinori Ito; Soyoko Morimoto; Kazuma Hara; Akihiro Tsuboi; Yoshihiro Oka; Satoru Yanagisawa; Yoichi Toyama; Masahiro Ikegami; Toru Kitagawa; Hidetoshi Eguchi; Hiroshi Wada; Hiroaki Nagano; Jun Nakata; Yoshiki Nakae; Naoki Hosen; Yusuke Oji; Toshio Tanaka; Ichiro Kawase; Atsushi Kumanogoh; Junichi Sakamoto; Yuichiro Doki; Masaki Mori; Toshifumi Ohkusa; Hisao Tajiri; Haruo Sugiyama
Journal:  J Immunother       Date:  2014 Feb-Mar       Impact factor: 4.456

9.  Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives.

Authors:  Chiara F Magnani; Sarah Tettamanti; Francesca Maltese; Nice Turazzi; Andrea Biondi; Ettore Biagi
Journal:  Front Oncol       Date:  2013-04-30       Impact factor: 6.244

10.  An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells.

Authors:  Kana Hasegawa; Satomi Tanaka; Fumihiro Fujiki; Soyoko Morimoto; Hiroko Nakajima; Naoya Tatsumi; Jun Nakata; Satoshi Takashima; Sumiyuki Nishida; Akihiro Tsuboi; Yoshihiro Oka; Yusuke Oji; Atsushi Kumanogoh; Haruo Sugiyama; Naoki Hosen
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.